Predictors and clinical implications of minimal ST-segment elevation in patients with ST-segment elevation myocardial

Se Yong Jang1, Myung Hwan Bae, Jae Hee Kim

  • 1Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.

Cardiology
|June 7, 2014
PubMed

Insights

Patients with minimal ST-segment elevation (STE) myocardial infarction (STEMI) have distinct characteristics, including a higher prevalence of women and better coronary blood flow. However, minimal STE does not predict a better prognosis compared to definite STEMI.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Medical Research

Background:

  • Some patients with suspected ST-elevation myocardial infarction (STEMI) present with ST-segment elevation (STE) not meeting current STEMI diagnostic criteria.
  • This subgroup, termed 'minimal STE,' requires further investigation regarding its unique patient characteristics and clinical outcomes.

Purpose of the Study:

  • To investigate the clinical characteristics of patients with minimal STE.
  • To evaluate the prognosis of patients diagnosed with minimal STE.

Main Methods:

  • A cohort of 546 patients undergoing primary percutaneous coronary intervention (PCI) for STEMI between November 2007 and December 2011 was analyzed.
  • Patients were categorized into minimal STE and definite STEMI groups.

Main Results:

  • The minimal STE group showed a higher proportion of women (30.2% vs. 21.0%), better pre-PCI antegrade flow (30.2% vs. 18.8%), and improved collateralization (27.4% vs. 18.1%) compared to the definite STEMI group.
  • Multivariate analysis identified female gender, good collateral flow, and good pre-PCI antegrade flow as independent predictors for minimal STE.
  • One-year mortality rates were similar between the minimal STE and definite STEMI groups (7.1% vs. 9.3%).

Conclusions:

  • Female gender, good collateral circulation, and adequate pre-PCI antegrade flow are significant predictors of minimal STE in STEMI patients.
  • Despite these distinct characteristics, minimal STE is not associated with an improved prognosis in patients with STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
923
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522